219 related articles for article (PubMed ID: 20021829)
21. Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies.
Li H; Hu B; Zhou ZQ; Guan J; Zhang ZY; Zhou GW
World J Surg Oncol; 2015 Apr; 13():161. PubMed ID: 25903488
[TBL] [Abstract][Full Text] [Related]
22. Intrahepatic cholangiocarcinoma arising in chronic viral hepatitis-associated cirrhosis: two transplant cases.
Nart D; Ertan Y; Pala EE; Zeytunlu M; Kilic M; Yilmaz F
Transplant Proc; 2008 Dec; 40(10):3813-5. PubMed ID: 19100500
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for cholangiocarcinoma.
Ben-Menachem T
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):615-7. PubMed ID: 17625428
[TBL] [Abstract][Full Text] [Related]
24. Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy.
Donato F; Gelatti U; Tagger A; Favret M; Ribero ML; Callea F; Martelli C; Savio A; Trevisi P; Nardi G
Cancer Causes Control; 2001 Dec; 12(10):959-64. PubMed ID: 11808716
[TBL] [Abstract][Full Text] [Related]
25. Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type.
Aishima S; Kuroda Y; Nishihara Y; Iguchi T; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
Am J Surg Pathol; 2007 Jul; 31(7):1059-67. PubMed ID: 17592273
[TBL] [Abstract][Full Text] [Related]
26. Intrahepatic cholangiocarcinoma and hepatitis: case study and literature review.
Luh F; Kuei A; Fann P; Chu P; Yen Y
Anticancer Res; 2009 Aug; 29(8):3239-43. PubMed ID: 19661341
[TBL] [Abstract][Full Text] [Related]
27. Detection of hepatitis B virus DNA in paraffin-embedded intrahepatic and extrahepatic cholangiocarcinoma tissue in the northern Chinese population.
Wu Y; Wang T; Ye S; Zhao R; Bai X; Wu Y; Abe K; Jin X
Hum Pathol; 2012 Jan; 43(1):56-61. PubMed ID: 21777950
[TBL] [Abstract][Full Text] [Related]
28. Diabetes mellitus and increased risk of extrahepatic cholangiocarcinoma: a meta-analysis.
Zhang LF; Zhao HX
Hepatogastroenterology; 2013 Jun; 60(124):684-7. PubMed ID: 23321031
[TBL] [Abstract][Full Text] [Related]
29. Cholangiocarcinoma.
Patel T
Nat Clin Pract Gastroenterol Hepatol; 2006 Jan; 3(1):33-42. PubMed ID: 16397610
[TBL] [Abstract][Full Text] [Related]
30. [Cholangiocarcinoma developing in von Meyenburg complexes in haemochromatosis].
Wisniewski B; Tordjman G; Tran Van Nhieu J; Bettan L; Courillon-Mallet A
Gastroenterol Clin Biol; 2002 Oct; 26(10):922-4. PubMed ID: 12434102
[TBL] [Abstract][Full Text] [Related]
31. [Descriptive epidemiology of intrahepatic cholangiocarcinoma].
Tsukuma H
Nihon Rinsho; 2001 Oct; 59 Suppl 6():25-32. PubMed ID: 11761949
[No Abstract] [Full Text] [Related]
32. Intrahepatic cholangiocarcinoma arising in cirrhotic liver frequently expressed p63-positive basal/stem-cell phenotype.
Nomoto K; Tsuneyama K; Cheng C; Takahashi H; Hori R; Murai Y; Takano Y
Pathol Res Pract; 2006; 202(2):71-6. PubMed ID: 16377099
[TBL] [Abstract][Full Text] [Related]
33. [Expression and significance of hepatitis B virus genes in human primary intrahepatic cholangiocarcinoma and its surrounding tissue].
Wang W; Gu G; Hu M
Zhonghua Zhong Liu Za Zhi; 1996 Mar; 18(2):127-30. PubMed ID: 9206046
[TBL] [Abstract][Full Text] [Related]
34. Double primary liver cancer (intrahepatic cholangiocarcinoma and hepatocellular carcinoma) in a patient with hepatitis C virus-related cirrhosis.
Inaba K; Suzuki S; Sakaguchi T; Kobayasi Y; Takehara Y; Miura K; Baba S; Nakamura S; Konno H
J Hepatobiliary Pancreat Surg; 2007; 14(2):204-9. PubMed ID: 17384916
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of congenital dilatation of the bile ducts. Apropos of 3 cases].
Berger A; Roger V; Wind P; Chevallier JM; Cugnenc PH
J Chir (Paris); 1997 Dec; 134(7-8):305-10. PubMed ID: 9772995
[TBL] [Abstract][Full Text] [Related]
36. Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002.
Jepsen P; Vilstrup H; Tarone RE; Friis S; Sørensen HT
J Natl Cancer Inst; 2007 Jun; 99(11):895-7. PubMed ID: 17551150
[TBL] [Abstract][Full Text] [Related]
37. Etiological and clinicopathologic characteristics of intrahepatic cholangiocarcinoma in young patients.
Zhou HB; Wang H; Zhou DX; Wang H; Wang Q; Zou SS; Hu HP
World J Gastroenterol; 2010 Feb; 16(7):881-5. PubMed ID: 20143468
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States.
Perumal V; Wang J; Thuluvath P; Choti M; Torbenson M
Hum Pathol; 2006 Sep; 37(9):1211-6. PubMed ID: 16938527
[TBL] [Abstract][Full Text] [Related]
39. [Cholangiocarcinoma in primary sclerosing cholangitis: "chronicle of a death foretold"?].
Margalit M; Elinav H; Goldin E; Ilan Y
Harefuah; 2003 Jun; 142(6):421-5, 486. PubMed ID: 12858825
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of risk factors for extrahepatic cholangiocarcinoma: ABO blood group, hepatitis B virus and their synergism.
Zhou Y; Zhou Q; Lin Q; Chen R; Gong Y; Liu Y; Yu M; Zeng B; Li K; Chen R; Li Z
Int J Cancer; 2013 Oct; 133(8):1867-75. PubMed ID: 23564396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
